Infection Surveillance Solution Market Size, Forecast [2031]
Infection Surveillance Solution Market Size, Forecast [2031]
Segments - Infection Surveillance Solutions Market by Offerings (Services [Implementation Service, Maintenance & Support, and Consultation & Training] and Software [Cloud-based and On-premise]), End-users (Long-term Care Facilities, Hospitals, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
Upcoming
| Report ID :ICT-SE-3987
| 4.7 Rating
| 64 Reviews
| 214 Pages
| Format :
Report Description
The global infection surveillance solution market size is anticipated to register a considerable CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the increasing incidences of hospital acquired infections across the globe.
Infection surveillance solution is a software that provides assistance to medical facilities, such as clinics, hospitals, and others to report the data associated with patients, to the federal and state authorities. According to, Centers for Disease Control, in American hospitals alone, hospitals acquired infections account for an estimated 99,000 deaths each year and 1.7 million infections. This software alerts healthcare facilities internet protocol in case of any hospital associated infections, such as surgical infections and urinary tract infection, occurred to the patient, so that hospital acquired specialists and nurses can provide effective and accurate treatment to the patients suffering from the infection in order to avoid outbreak of infection.
Infection surveillance systems are designed to continuously monitor and analyze health-related data in order to ensure that preventive measures are implemented correctly. These solutions are implemented to detect the infections along with assessing the preventive measures as well as calculate the success of infection prevention and control plans to find the area of improvement. They are also adopted to help in detection of infections caused by non-sterilized medical devices and in identifying antibiotic-resistant microorganisms. The software uses surveillance techniques to regulate infection controls. The infection surveillance solution systems offers several benefits to the healthcare facilities, including surgical databases maintenance, accurate employee health information, electronic healthcare records, maintenance of real-time medical records, and real-time pharmacy.
The COVID-19 pandemic outbreak had positively impacted the global infection surveillance solution market. During the pandemic, the healthcare system across the globe witnessed the major shortage of hospital beds, healthcare providers, and basic medical supplies. Additionally, the risk of hospital acquired infections is increased in patients of COVID-19, this is compelling the healthcare facilities to adopt infection control surveillance system to manage the data related to patient’s healthcare and get the insights from the data to effectively manage the pandemic situation.
Market Trends, Drivers, Restraints, and Opportunities
- Rising investments by government and non-government organization for various programs related to infection surveillance is one of the key factors driving the market.
- Surging number of surgical procedures and growing geriatric population, which are more susceptible to infections is projected to boost the market during the forecast period.
- High cost associated with deployment and maintenance of infection surveillance system act as major challenges that can restrict the market growth in the coming years.
- Lack of information technology professionals in healthcare sector is expected to hamper the market growth during the projected timeline.
- Increasing healthcare expenditure especially in developing countries is anticipated to create significant growth opportunities for the market.
Scope of Infection Surveillance Solutions Market Report
The report on the global infection surveillance solution market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Infection Surveillance Solution Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Offerings (Services [Implementation Service, Maintenance & Support, and Consultation & Training] and Software [Cloud-based and On-premise]) and End-users (Long-term Care Facilities, Hospitals, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
IBM Corp. (Truven Health Analytics); VigiLanz Corp.; RL Solutions; Cerner Corp.; and Gojo Industries Inc. |
Infection Surveillance Solutions Market Segment Insights
Software segment to grow at rapid pace
Based on offerings, the global infection surveillance solution market is bifurcated into services and software. The services segment is sub-categorized into implementation service, maintenance & support, and consultation & training. The software segment is further bifurcated into cloud-based and on-premise. The software segment is expected to grow at a rapid pace during the forecast period due to the increasing need of healthcare facilities to prevent hospital acquired infections incidences. However, the services segment is projected to expand at a substantial growth rate in the coming years attributed to the rising need for maintaining access to healthcare information technology solutions.
Growing surgical procedures drives the hospitals segment
On the basis of end-users, the market is divided into long-term care facilities, hospitals, and others. The hospitals segment is projected to expand at robust growth rate during the forecast period attributed to the large patient volume, increasing number of surgical procedures, and risk of infection associated with it. Additionally, increasing adoption of infection surveillance system by hospitals to maintain electronic health records is driving the segment growth further. On the other hand, the long-term care facilities segment is anticipated to expand at a substantial CAGR during the forecast period owing to the growing geriatric population.
North America to constitute a key market share
In terms of geography, the global infection surveillance solution market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key share of the market during the projected period owing to the presence of the well-established healthcare sector, growing R&D activities in medical science and increasing healthcare expenditure in the region. However, the market of Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to the increasing incidences of hospital acquired infections, significant advancements in health insurance sector, and rising government spending on healthcare sector in the region.
Segments
The global infection surveillance solution market has been segmented on the basis of
Offerings
- Services
- Implementation Service
- Maintenance & Support
- Consultation & Training
- Software
- Cloud-based
- On-premise
End-users
- Long-term Care Facilities
- Hospitals
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- IBM Corp. (Truven Health Analytics)
- VigiLanz Corp.
- RL Solutions
- Cerner Corp.
- Gojo Industries Inc.
Competitive Landscape
Key players competing in the global infection surveillance solution market are IBM Corp. (Truven Health Analytics); VigiLanz Corp.; RL Solutions; Cerner Corp.; and Gojo Industries Inc. Companies are focusing on investment in R&D for technological advancements in information surveillance software to maintain their competitive position in the market. Companies have been widely engaged in strategic partnership, merger & acquisition, new product launch, and collaborations to boost their market share and acquire new buyers.
For instance, in June 2021, bioMérieux SA, a French multinational biotechnology company announced a launch of EPISEQ SARS-CoV-2, surveillance software application planned to detect variants using samples from positive patients. The cloud-based application automatically update each week, the platform recognizes variations based on international nomenclatures, including any new variant of concern as defined by the US Centers for Disease Control and Prevention and the World Health Organization. In May 2019, iContracts acquired RL Solutions. This acquisition brings together the iContracts’ leading policy management capabilities and RLDatix patient safety platform to life sciences organisations navigate complex revenue management processes and allow healthcare organizations for manage risk and compliance.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Infection Surveillance Solution Market Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Infection Surveillance Solution Market Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Infection Surveillance Solution Market Market - Supply Chain
4.5. Global Infection Surveillance Solution Market Market Forecast
4.5.1. Infection Surveillance Solution Market Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Infection Surveillance Solution Market Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Infection Surveillance Solution Market Market Absolute $ Opportunity
5. Global Infection Surveillance Solution Market Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Infection Surveillance Solution Market Market Size and Volume Forecast by End Users
5.3.1. Long-term Care Facilities Hospitals Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Infection Surveillance Solution Market Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Infection Surveillance Solution Market Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Infection Surveillance Solution Market Demand Share Forecast, 2019-2026
7. North America Infection Surveillance Solution Market Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Infection Surveillance Solution Market Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Infection Surveillance Solution Market Market Size and Volume Forecast by End Users
7.4.1. Long-term Care Facilities Hospitals Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Infection Surveillance Solution Market Demand Share Forecast, 2019-2026
8. Latin America Infection Surveillance Solution Market Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Infection Surveillance Solution Market Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Infection Surveillance Solution Market Market Size and Volume Forecast by End Users
8.4.1. Long-term Care Facilities Hospitals Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Infection Surveillance Solution Market Demand Share Forecast, 2019-2026
9. Europe Infection Surveillance Solution Market Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Infection Surveillance Solution Market Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Infection Surveillance Solution Market Market Size and Volume Forecast by End Users
9.4.1. Long-term Care Facilities Hospitals Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Infection Surveillance Solution Market Demand Share Forecast, 2019-2026
10. Asia Pacific Infection Surveillance Solution Market Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Infection Surveillance Solution Market Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Infection Surveillance Solution Market Market Size and Volume Forecast by End Users
10.4.1. Long-term Care Facilities Hospitals Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Infection Surveillance Solution Market Demand Share Forecast, 2019-2026
11. Middle East & Africa Infection Surveillance Solution Market Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Infection Surveillance Solution Market Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Infection Surveillance Solution Market Market Size and Volume Forecast by End Users
11.4.1. Long-term Care Facilities Hospitals Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Infection Surveillance Solution Market Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Infection Surveillance Solution Market Market: Market Share Analysis
12.2. Infection Surveillance Solution Market Distributors and Customers
12.3. Infection Surveillance Solution Market Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. IBM Corp. (Truven Health Analytics) VigiLanz Corp. RL Solutions Cerner Corp. Gojo Industries Inc.
Methodology
Related Reports
Some other reports from this category!
Our Clients
